Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Risk Factors Associated With Resistance to Antiviral Therapy in Egyptian Patients With Chronic Hepatitis B Virus Infection

NCT07274345 is registered in ClinicalTrials.gov with Amira Mohamed Zidan as lead sponsor.

NCT NCT07274345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07274345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Risk Factors Associated With Resistance to Antiviral Therapy in Egyptian Patients With Chronic Hepatitis B Virus Infection
Lead sponsor
Amira Mohamed Zidan
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 1, 2026
Enrollment
2,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b - antiviral drug resistance - hepatitis b virus (hbv) infection